Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
4 | 55084031 | intron variant | A/T | snv | 0.28 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 0.040 | 4 | 55087316 | intron variant | G/A | snv | 7.6E-02 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.080 | 4 | 55088939 | missense variant | G/A;C | snv | 9.2E-05; 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.800 | 1.000 | 3 | 2002 | 2008 | |||||||
|
0.925 | 0.080 | 4 | 55088939 | missense variant | G/A;C | snv | 9.2E-05; 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2002 | 2002 | |||||||
|
0.925 | 0.080 | 4 | 55089065 | intron variant | T/A;C | snv |
|
Eye Diseases | 0.020 | 1.000 | 2 | 2012 | 2019 | ||||||||
|
0.925 | 0.080 | 4 | 55089065 | intron variant | T/A;C | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
4 | 55089696 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
4 | 55089696 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
4 | 55089696 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
4 | 55089798 | missense variant | C/T | snv | 2.4E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
0.827 | 0.160 | 4 | 55089802 | missense variant | C/T | snv | 5.3E-04 | 4.1E-04 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.827 | 0.160 | 4 | 55089802 | missense variant | C/T | snv | 5.3E-04 | 4.1E-04 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.827 | 0.160 | 4 | 55089802 | missense variant | C/T | snv | 5.3E-04 | 4.1E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.827 | 0.160 | 4 | 55089802 | missense variant | C/T | snv | 5.3E-04 | 4.1E-04 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.827 | 0.160 | 4 | 55089802 | missense variant | C/T | snv | 5.3E-04 | 4.1E-04 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
4 | 55092041 | intron variant | T/C | snv | 7.9E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 4 | 55100286 | intron variant | C/T | snv | 0.21 |
|
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.160 | 4 | 55100634 | intron variant | C/T | snv | 0.59 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.160 | 4 | 55100634 | intron variant | C/T | snv | 0.59 |
|
Eye Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.080 | 4 | 55105679 | intron variant | G/T | snv | 0.35 |
|
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 4 | 55106779 | missense variant | A/G | snv | 2.3E-02 | 2.3E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.882 | 0.160 | 4 | 55106779 | missense variant | A/G | snv | 2.3E-02 | 2.3E-02 |
|
0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.160 | 4 | 55106779 | missense variant | A/G | snv | 2.3E-02 | 2.3E-02 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.160 | 4 | 55106779 | missense variant | A/G | snv | 2.3E-02 | 2.3E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.882 | 0.160 | 4 | 55106779 | missense variant | A/G | snv | 2.3E-02 | 2.3E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 |